Rahul Aggarwal

MD

Developmental therapeutics specialist
Genitourinary oncologist
Cancer researcher and sports enthusiast

Dr. Rahul Aggarwal is a specialist in cancers of the genital and urinary organs. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men who are receiving androgen deprivation therapy, hormone therapy for prostate cancer.

As a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early-phase clinical trials of novel targeted treatments. His research focuses on developing hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. He is also interested in developing new molecular imaging techniques that will help predict how advanced solid tumors will respond to treatment.

Aggarwal earned his medical degree from the Northwestern University Feinberg School of Medicine. At UCSF, he completed an internship and residency in internal medicine, followed by a clinical fellowship in hematology and oncology.

Aggarwal has also been a research fellow in developmental therapeutics at Genentech. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award.

  • Education

    Northwestern University Feinberg School of Medicine, 2006

  • Residencies

    UCSF Medical Center, Internal Medicine, 2009

  • Fellowships

    UCSF Medical Center, Hematology/Oncology, 2013

  • Board Certifications

    Medical Oncology, American Board of Internal Medicine

    Hematology, American Board of Internal Medicine

  • Academic Title

    Associate Professor

It's an honor to help take care of people with cancer, and I strive each and every day to improve outcomes for our patients.

Conditions I specialize in

Where I see patients (4)

    My reviews

    4.9

    Overall Experience
    445 Ratings
    About our process
    Jun 22, 2023
    Dr. Aggarwal is the best.!!
    Jun 13, 2023
    Dr. Aggarwal is a caring knowledgeable and skillful physician. He is empathic and considerate. We're very grateful for his care! Perhaps it would be useful to have a little more time to discus or hear his understanding of the development of patient's conditions and overall outlook on his progress.
    May 31, 2023
    Excellent care-
    May 19, 2023
    Dr Aggarwal is the best!
    May 18, 2023
    Dr. Aggarwal is excellent in his knowledge professional and communication skills. I feel quite fortunate to be able to work with him.
    May 16, 2023
    Great
    May 04, 2023
    I have built a strong trusted relationship with Dr Aggarwal over many years and treatments. He fully understands my goals has delivered outstanding (world class) care and remembers my unique situation each time we meet.
    Apr 26, 2023
    The care is second to none. His entire staff is amazing!
    Apr 21, 2023
    I really like Dr Aggarwal he has always been very attentive knowelegable and caring
    Mar 25, 2023
    DR AGGARWAL IS THE BEST.
    Mar 23, 2023
    Comments meant for Dr Aggarwal
    Mar 22, 2023
    Excellent quality of care
    Mar 21, 2023
    I'm lucky to have Dr. Aggarwal as my oncologist. He's easy to talk to open to questions encourages discussion about treatment and how I'm doing.
    Mar 15, 2023
    Dr. Aggarwal is kind and compassionate.
    Mar 01, 2023
    Excellent
    Mar 01, 2023
    Great Doc!!!!!
    Feb 15, 2023
    I would have liked a walkthrough of my PSMA scan like I've had in previous appointments
    Jan 31, 2023
    Dr Aggarwal is very professional and yet friendly and approachable.
    Jan 31, 2023
    Excellent provider--exceptionally knowledgeable
    Jan 31, 2023
    Dr. Aggarwal explained the cancer trial thoroughly answered all my questions and was friendly and professional.
    Jan 31, 2023
    Dr. Aggarwal is one of those rare physicians who manages to maintain his professional objectivity and expertise while being truly friendly and empathetic even in the face of often dire cancer prognoses. I am very privileged to have as my primary Med Onc.
    Jan 27, 2023
    Wonderful treatment as always. The high bar that UCSF has set for my treatment expectations has yet to disappoint from the valet initial COVID screening check in treatment and dismissal - I have experienced no weak links.
    Jan 26, 2023
    Dr Aggarwal is the BEST doctor we ever have worked with.
    Jan 22, 2023
    Tele health is the way to go .
    Jan 11, 2023
    Dr. Aggarwal is the best. Listens is never rushed and an expert. Doesn't get any better.
    Dec 16, 2022
    Dr Aggarwal was thorough in his explanations and very professional in his discussion. He was knowledgeable and approachable -
    Dec 16, 2022
    Extraordinarily clear communication of information.
    Dec 14, 2022
    Answered all questions in a detailed and caring manner
    Dec 04, 2022
    Dr. Aggarwal is the best we are truly blessed to have him as our physician.
    Nov 30, 2022
    Dr Aggarwal is EXCELLENT!
    Nov 30, 2022
    Dr. Aggarwal is one of the finest persons you will ever meet and he is a rock star of a doctor!
    Nov 10, 2022
    Dr. Rahul Aggarwal has been my lead guy for many years now 6+. I value his experience wisdom and calm demeanor. He listens well and incorporates my goals & concerns into his care plan. We've gotten great results to celebrate.
    Oct 13, 2022
    Expert care!
    Oct 13, 2022
    My caregiver is both very knowledgeable and amicable.
    Sep 29, 2022
    I really respect Dr. Aggarwal for his professionalism knowledge and kindness.
    Sep 29, 2022
    Very helpful meeting
    Sep 28, 2022
    Dr.Aggarwal is the absolute best doctor I have ever had. I can't say anything negative about him. Absolutely outstanding!!!
    Sep 28, 2022
    I have the highest degree of trust and confidence in Dr. Aggarwal. Plus he is a very approachable and friendly health professional.
    Sep 27, 2022
    It was a very comfortable and non intimidating exchange.
    Sep 23, 2022
    Consistently demonstrated is genuine care for my condition.
    Sep 21, 2022
    Although I transferred my care from another provider to UCSF Dr Aggarwal and staff could not have been more welcoming.
    Aug 27, 2022
    All good
    Aug 17, 2022
    I've already recommended six people do UCSF oncology department one with pancreatic cancer one with a cyst on his kidney and three others that have fairly high velocity of rising PSA. And I don't refer people easily I've been a contractor for 50 years and it's a good way to get people mad at you when they're not happy with the person you referred them to a person the people I referred have reported back to me thank you very much for that referral I really felt taken care of when I went there and they were talking about you guys so take it to heart thanks for your great work
    Aug 03, 2022
    Dr Aggarwal was very attentive and thorough he took time to explain the treatment plan and answer all my questions.
    Jul 29, 2022
    Dr Aggarwal is an excellent practitioner. He is personable engaged and genuinely interested in the total well being of the patient. This was our second meeting and it was fully consistent with the fine rapport we established in the first.
    Jun 13, 2022
    Dr. Aggarwal is always mindful of my concerns.
    May 29, 2022
    Very good experience
    May 28, 2022
    Excellent
    May 26, 2022
    Dr Aggarwal is an amazing person and doctor.
    May 18, 2022
    At one point you were going to record the dr patient covers atin? and make it available to the patient. Why isn't that being done. Would be a lot more helpful than the dr notes
    May 06, 2022
    We have generally been very pleased and grateful for the quality of care received by the oncology team at UCSF.
    May 05, 2022
    Dr. Aggarwal is one of the best human beings I have ever met. This continues over into his practice- I always feel safe.
    May 03, 2022
    Dr. Aggarwal promptly posted an after-visit note and he and his team followed up on everything in a very timely manner. Impressive!
    Apr 27, 2022
    I'm very fortunate to be receiving World Class care at UCSF almost 14 years now.
    Apr 03, 2022
    Very satisfied with all experiences involving Dr. Aggarwal & Staff
    Mar 30, 2022
    Dr. Aggarwal and team are tops.
    Mar 08, 2022
    Excellent experience.
    Mar 04, 2022
    Exceptional--I just don't give out 10s. Dr. Agarrwal is a superb clinician
    Feb 24, 2022
    Dr Aggarwal is top notch. I am very fortunate to have UCSF support and world class care providers.
    Feb 21, 2022
    Dr.Aggarwal has been and continues to be superb in treating me and addressing anything I bring to him. Can't say enough superlatives about him
    Feb 08, 2022
    Dr. Aggarwal is polite and listens intently to my questions and concerns.
    Jan 31, 2022
    All experiences with Dr. Aggarwal & staff have been very good.
    Jan 29, 2022
    The doctor is an excellent care provider and has great bedside mannerisms.
    Jan 08, 2022
    All good not any bad
    Nov 17, 2021
    Best care I've ever had
    Nov 16, 2021
    No mention of a 2nd clinical trial option I had been led to believe would be the subject of discussion. Introduction of yet another trial. Only passing mention of standard of care options compared to new trial. Clinicians were cordial but showed little concern for patient's sense of urgency for a treatment plan. Written after visit summary much more clear.
    Oct 31, 2021
    Everyone is ready to help you out if you need it or get some one that can help you
    Oct 06, 2021
    Dr Aggarwal is a great doctor and I am so happy that he is my doctor
    Sep 22, 2021
    All good
    Sep 21, 2021
    There were a couple of minor mistakes on the after visit summary ...which I corrected with a follow up message in the portal.
    Sep 18, 2021
    Dr. Aggarwal is a wonderful and engaged physician.
    Sep 16, 2021
    All experiences were excellant
    Sep 13, 2021
    Could not connect. Waiting for call back.

    Selected research

    See all research
    Decorative Caduceus

    Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

    rPFS is defined as the amount of time from the initiation of study therapy and the day of first documented radiographic disease progression per RECIST version 1.1 and PCWG3 criteria. The proportion of patients without radiographic...

    Recruiting

    Decorative Caduceus

    FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostat...

    A minimum of 3 patients will be treated at each dose level. If < 33%of patients (i.e. 0 of 3 patients, or 1 of 6 patients) within a cohort have a dose-limiting toxicity (DLT in Cycle 1, then enrollment of the next cohort may comme...

    Recruiting

    Decorative Caduceus

    64Cu-GRIP B in Patients With Advanced Genitourinary Malignancies

    For Cohort A, the frequency and severity of adverse events following 64Cu-GRIP B injection will be descriptively reported, using NCI Common Terminology Criteria for Adverse Events (CTCAE) version 5.0

    Recruiting

    Decorative Caduceus

    APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation ...

    Adverse events, serious adverse events, and dose limiting toxicities

    Recruiting

    Decorative Caduceus

    Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocy...

    Treatment-related adverse events as assessed by CTCAE v4.0

    Recruiting

    Decorative Caduceus

    ZEN-3694, Enzalutamide, and Pembrolizumab for the Treatment of Metastatic Castration-Resistant ...

    Defined as either objective response per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria (complete response (CR), partial response (PR)) or confirmed >= 50% decline from serum prostate-specific antigen (PSA) at ...

    Recruiting

    Decorative Caduceus

    Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With So...

    On overall response will be reported as a percentage of participants with a complete response (CR) or partial response (PR) as measured by the Response Evaluation Criteria in Solid Tumors (RECIST) version 1.1

    Recruiting

    Decorative Caduceus

    Apalutamide With or Without Stereotactic Body Radiation Therapy in Treating Participants With C...

    The primary endpoint for the study is the proportion of patients with undetectable serum PSA (< 0.2 ng/mL) at 6 months following completion of apalutamide therapy (18 months from date of randomization). Patients who discontinue ap...

    Recruiting

    Decorative Caduceus

    Pilot Study of (MR) Imaging With Pyruvate (13C) to Detect High Grade Prostate Cancer

    Means and standard deviations for lactate area under curve will be calculated by pathologic grade (benign, low grade (primary Gleason score <4) and high grade (primary Gleason score >4)). A One-way ANOVA model will be used to comp...

    Recruiting

    Decorative Caduceus

    A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

    To determine the maximum tolerated dose (MTD) and/or recommended dose (RD) for further evaluation of XL092 when administered alone and in combination with immune checkpoint inhibitors (ICIs) to subjects with advanced solid tumors

    Recruiting

    Contact me

    Share